Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CMPS compared with RARE: revenue, margins and what each company keeps, and the suppliers and customers both name
CMPS
COMPASS Pathways plc
Change
Mkt cap
Revenue
Revenue
RARE
Ultragenyx Pharmaceutical Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CMPS
COMPASS Pathways plc
vs
RARE
Ultragenyx Pharmaceutical Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CMPS
0
None
Shared
0
No disclosed counterparties: CMPS.
Only RARE
23
—
Undisclosed supplier
unlisted
supplier
TMO
Patheon Pharma Services by ThermoFisher Scientific
supplier
REGN
Regeneron Pharmaceuticals
supplier
BAX
Baxter Pharmaceutical Solutions
supplier
19 more · RARE chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CMPS
COMPASS Pathways plc
Change
11.57
▼
−5.09%
· post 11.62
Mkt cap
$1.6B
Revenue
—
Revenue
—
RARE
Ultragenyx Pharmaceutical Inc.
Change
16.10
▼
−4.05%
· post 16.06
Closed
Oct 30 '26
Mkt cap
$1.6B
Revenue
$214M
Q2 FY26
Revenue
$673M
FY25
vs
Compare
Closed
Oct 30 '26
CMPS
COMPASS Pathways plc
vs
RARE
Ultragenyx Pharmaceutical Inc.
11.57
▼
−5.09%
post 11.62
Price
16.10
▼
−4.05%
post 16.06
$1.6B
Mkt cap
$1.6B
—
Revenue
$214M
Q2 FY26
—
Revenue
$673M
FY25
Change
Change
CMPS
11.57
▼
−5.09%
vs
RARE
16.10
▼
−4.05%
Closed
Oct 30 '26